Buchumschlag

Letter: Reinterpreting the Role of Microbiota‐Driven Nitric Oxide in Cirrhotic Portal Hypertension—A Maladaptive Compensatory Response?

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Meiyu Yang, Tiantian Zhang, Susu Zhang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Letter: Methodological Caveats in Zhang et al.–Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension
von: Muhammad Talha Ghaffar
Veröffentlicht: (2025)

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression
von: Qun Zhang, et al.
Veröffentlicht: (2025)

Letter: Unmasking the Risks—The Need for Robust Data on Baclofen in Cirrhotic Patients
von: Zainab Salman
Veröffentlicht: (2026)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
von: Lukas Burghart, et al.
Veröffentlicht: (2026)

Editorial: Is TIPSS Implantation Effective in Patients With Portal Hypertensive Gastropathy?
von: Marlene Reincke, et al.
Veröffentlicht: (2024)

Editorial: Carvedilol Remains the First‐Line Treatment of Portal Hypertension After the CALIBRE Trial
von: Thomas Reiberger, et al.
Veröffentlicht: (2025)

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study
von: Mitchell Shiffman, et al.
Veröffentlicht: (2024)

Letter on ‘Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicentre Real‐World’
von: Silvia Nardelli, et al.
Veröffentlicht: (2025)

Letter: Statins for Cirrhosis: Are We Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management?
von: Abdulrahman Ismaiel
Veröffentlicht: (2026)

Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End‐Stage Liver Disease—Authors' Reply
von: Mattias Mandorfer, et al.
Veröffentlicht: (2025)

Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study
von: Yi Xiang, et al.
Veröffentlicht: (2025)

Letter: Statins for Cirrhosis: Are we Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? Authors' Reply
von: Bernardo de Faria Moraes, et al.
Veröffentlicht: (2026)

Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Authors' Reply
von: Sara Ellegaard Paaske, et al.
Veröffentlicht: (2026)

Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis
von: Ewan Forrest, et al.
Veröffentlicht: (2025)

Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non‐Cirrhotic Patients
von: Ming Liu, et al.
Veröffentlicht: (2025)

Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study
von: Manon Evain, et al.
Veröffentlicht: (2025)

Letter: Supporting the Role of Enzyme Therapy in Management of Coeliac Disease
von: Finlay Macrae
Veröffentlicht: (2025)

Letter: The Prognostic Role of IGF‐1 in Chronic Liver Disease
von: Muhammad Osama, et al.
Veröffentlicht: (2024)

Letter: Predictors of Corticosteroid Response in Alcohol‐Related Hepatitis—Authors' Reply
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2025)

Letter: A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
von: Xiaojuan Liu, et al.
Veröffentlicht: (2025)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—An emulated clinical trial
von: Mingsi Zhang, et al.
Veröffentlicht: (2024)

Letter: Timely Follow‐Up in Cirrhosis—A Key Public Health Intervention
von: Mo‐Yao Tan, et al.
Veröffentlicht: (2024)

Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease
von: Qiong Yi, et al.
Veröffentlicht: (2024)

Maladaptive weight control and eating behaviours in female adolescents/young adults are associated with increased risk of irritable bowel syndrome in adulthood: Results from the Growing Up Today Study (GUTS)
von: Keming Yang, et al.
Veröffentlicht: (2024)

Letter: A Patient Centric Approach to Tapering Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis
von: Ganesh Bhat, et al.
Veröffentlicht: (2026)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
von: Jian Wang, et al.
Veröffentlicht: (2024)

Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH
von: Jannis Kountouras, et al.
Veröffentlicht: (2024)

Letter: The Essential Role of Social Workers in Reducing Socioeconomic Disparities in Chronic Liver Disease—Author's Reply
von: Eunice Yewon Lee, et al.
Veröffentlicht: (2024)

Letter: Social work and clinical synergy—Optimising health interventions for elderly DGBI populations
von: Rui Zhang, et al.
Veröffentlicht: (2024)

Letter: A Patient Centric Approach to Tapering Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis. Authors' Reply
von: Amol N. Patil, et al.
Veröffentlicht: (2026)

Letter on ‘Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis’
von: Yi Pei, et al.
Veröffentlicht: (2025)

Letter: Interpreting Faecal SCFA Enrichment in IBS‐D—Metabolic Signal or Transit‐Related Marker?
von: Longying Zhang, et al.
Veröffentlicht: (2026)

Letter: The Hidden Truth of IBD Risk—From Antibiotics to Environmental Factors
von: Xueneng Yang, et al.
Veröffentlicht: (2025)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
von: Jian Wang, et al.
Veröffentlicht: (2024)

Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis? Authors' Reply
von: Hong‐Li Liu, et al.
Veröffentlicht: (2026)

Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH—Authors’ reply
von: S. K. Bansal, et al.
Veröffentlicht: (2024)

Editorial: Safety and Effects of Direct Oral Anticoagulants for Portal Vein Thrombosis
von: Nina Kimer, et al.
Veröffentlicht: (2025)

Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma
von: Sifu Yang
Veröffentlicht: (2025)

Letter: Myokines Are Also Associated With Disease Course in Primary Biliary Cholangitis
von: Leyu Zhou, et al.
Veröffentlicht: (2024)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease
von: Jiahao Liu, et al.
Veröffentlicht: (2026)